ArticleAnnals of clinical and translational neurology2025

Real World Effectiveness and Tolerability of Novel Monoclonal Antibodies and Rituximab for NMOSD.

Zarmina Javed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.